RECOMB Project: Gene therapy for SCID

July 2018

From the foundation, we support the RECOMB project, which aims to develop gene therapy for patients with Severe Combined Immunodeficiency (SCID) or "Bubble Boys" with mutations in RAG1.

The research group "Infection in the Pediatric Patient Immunodeprimit" of the Vall d'Hebron Research Institute (VHIR) participates in the RECOMB project, which is funded by the research program Horizon2020 of the European Commission.

Here you can see more information: http://www.recomb.eu/wp-content/…/2018/07/Recomb_Leaflet.pdf